MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Validation of the performance based Erlangen Test of Activities of Daily Living in PD

I. Liepelt-Scarfone, L. Liebig, P. Sulzer, D. Berg (Tübingen, Germany)

Meeting: 2017 International Congress

Abstract Number: 104

Keywords: Dementia, Non-motor Scales, Parkinsonism

Session Information

Date: Monday, June 5, 2017

Session Title: Parkinson's Disease: Non-Motor Symptoms

Session Time: 1:45pm-3:15pm

Location: Exhibit Hall C

Objective: The Erlangen Test of Activities of Daily Living (E-ADL) is a performance-based test to assess the activity of daily living (ADL) dysfunction associated with Alzheimer’s disease. Here, we evaluated the objectivity, reliability, and validity of the E-ADL for cognitive impairment and dementia in Parkinson’s disease (PD).

Background: Cognitive decline that lowers ADL abilities is the core feature of Parkinson’s disease dementia (PDD). Most assessments measure ADLs indirectly, as they are questionnaires, which are self-reported, relative-reported or caretaker/nurse-reported. Although these measures are quick and economical, they are limited in their objectivity. For an early and valid diagnosis of PDD, an unbiased, quick, and easy to administer ADL assessment is needed.

Methods: Data of 106 PD patients, assigned to the groups of no cognitive impairment (PD-NC, n=40), mild cognitive impairment (PD-MCI, n=45) and PDD (n=21) were analyzed. The E-ADL consists of five tasks relevant to daily living: (1) pouring a drink, (2) cutting a piece of bread, (3) opening a little cupboard, (4) washing hands, and (5) tying a bow. Further ADL (e.g. Multiple Object Test, Schwab & England Scale), motor (e.g. Hoehn & Yahr stage) and non-motor (e.g. Beck Depression Inventory, Neuropsychiatric Inventory) assessments were applied.

Results:  Good objectivity of the E-ADL could be determined by the means of high inter-rater reliability (rs = 0.85). Item discrimination, Cronbach’s alpha (0.31), and inter-item correlation indicated little redundancy amongst items. High values in item difficulty (> 90%) showed that the test was too easy for most patients. Construct validity revealed relation of the E-ADL and other ADL measures indicating that the E-ADL was a valid test to assess ADL performance. Additionally, correlations of the E-ADL performance with motor performance (p<0.001) and mood (p<0.001) were detected. An ordinal regression and Receiver Operating Characteristics (ROC) analysis revealed that the E-ADL was not able to discriminate between PD-NC and PD-MCI, but was sufficient for diagnosis of PDD (Sensitivity 66%; specificity 77%).

Conclusions: The E-ADL is an easily administered test with good objectivity and validity for diagnosis of PDD. However, its discriminant ability for the early stages of PDD is low.

To cite this abstract in AMA style:

I. Liepelt-Scarfone, L. Liebig, P. Sulzer, D. Berg. Validation of the performance based Erlangen Test of Activities of Daily Living in PD [abstract]. Mov Disord. 2017; 32 (suppl 2). https://www.mdsabstracts.org/abstract/validation-of-the-performance-based-erlangen-test-of-activities-of-daily-living-in-pd/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/validation-of-the-performance-based-erlangen-test-of-activities-of-daily-living-in-pd/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley